Fulltext

Highly Cited Articles in the Field of Male Infertility and Antioxidants: A Scientometric Analysis

Agarwal A 1 , Selvam MKP 2 , Baskaran S 2 , Finelli R 2 , Leisegang K 3 , Barbăroșie C 4 Show all authors , Pushparaj PN 5 , Robert KA 2 , Ambar RF 6 , Iovine C 7 , Durairajanayagam D 8 , Henkel R 2

Affiliations 

  • 1 American Center for Reproductive Medicine, Cleveland Clinic, Cleveland, OH, USA. agarwaa@ccf.org
  • 2 American Center for Reproductive Medicine, Cleveland Clinic, Cleveland, OH, USA
  • 3 School of Natural Medicine, Faculty of Community and Health Sciences, University of the Western Cape, Bellville, South Africa
  • 4 Department of Genetics, Faculty of Biology, University of Bucharest, Bucharest, Romania
  • 5 King Abdulaziz University, Center of Excellence in Genomic Medicine, Jeddah, Saudi Arabia
  • 6 Urology Department of Centro Universitario em Saude do ABC/Andrology Group at Ideia Fertil Institute of Human Reproduction, Santo André, Brazil
  • 7 Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania Luigi Vanvitelli, Caserta, Italy
  • 8 Department of Physiology, Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh Campus, Selangor, Malaysia
World J Mens Health, 2021 Oct;39(4):760-775.
PMID: 33663027 DOI: 10.5534/wjmh.200181

Abstract

PURPOSE: The objective of this scientometric analysis was to recognize the top 100 cited articles on 'Male infertility and Antioxidants' and analyze its publication characteristics.

MATERIALS AND METHODS: The Scopus database was used to retrieve related articles and the top 100 identified based on citation rate.

RESULTS: The articles were published in 56 journals between 1995 and 2019 with a median (interquartile range) citation score of 17 (5-62). Among the top 100 articles, 69 were clinical studies, which included controlled and blinded (33.33%), prospective (27.54%), randomized-controlled trials (26.09%), uncontrolled (11.59%), and retrospective (1.45%) studies. In addition to conventional semen parameters, advanced sperm function tests such as oxidative stress (51%) and sperm DNA damage (23%) were reported. Pregnancy rate (33%) was found to be the most reported reproductive outcome. Antioxidant therapy was mostly investigated in male cohorts with sperm abnormalities such as asthenozoospermia (28%) and clinical conditions such as idiopathic male infertility (20%), varicocele/varicocelectomy (17%) and general male infertility (16%).

CONCLUSIONS: The most influential publications on antioxidants and male infertility were identified for the first time in the literature. This will serve as a reliable source of information for researchers and clinicians alike.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications